Clinical data | |
---|---|
Other names | 5-Phenyl-5-allylbarbituric acid |
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider |
|
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.003.718 |
Chemical and physical data | |
Formula | C13H12N2O3 |
Molar mass | 244.250 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Alphenal (Alphenal, Efrodal, Prophenal, Sanudorm), also known as 5-allyl-5-phenylbarbituric acid, is a barbiturate derivative developed in the 1920s.[1] It has primarily anticonvulsant properties, and was used occasionally for the treatment of epilepsyorconvulsions, although not as commonly, as better known barbiturates such as phenobarbital.[2][3] [4][5]
LD50: Mouse (Oral): 280 mg/kg
| |
---|---|
Alcohols |
|
Barbiturates |
|
Benzodiazepines |
|
Carbamates |
|
Flavonoids |
|
Imidazoles |
|
Kava constituents |
|
Monoureides |
|
Neuroactive steroids |
|
Nonbenzodiazepines |
|
Phenols |
|
Piperidinediones |
|
Pyrazolopyridines |
|
Quinazolinones |
|
Volatiles/gases |
|
Others/unsorted |
|
See also: Receptor/signaling modulators • GABA receptor modulators • GABA metabolism/transport modulators |
This anticonvulsant-related article is a stub. You can help Wikipedia by expanding it. |
This sedative-related article is a stub. You can help Wikipedia by expanding it. |